Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain

NCT06747728 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Brain Glioma

Interventions

DRUG: Bevacizumab

Sponsor

The First Affiliated Hospital of Zhengzhou University